ArabFinance: Minapharm Pharmaceuticals (Minapharm) (MIPH) reported an increase in profits for the full year ended December 31st 2021, according to the company’s financial statements filed to the Egyptian Exchange (EGX) on March 31st.

The company recorded a consolidated net profit attributable to the parent company of EGP 466.406 million in 2021, compared to a profit of EGP 300.78 million in 2020.

Consolidated sales amounted to EGP 3.005 billion last year, up from EGP 2.36 billion in 2020.

Meanwhile, the company’s standalone net profit after tax rose to EGP 275.45 million in 2021 from EGP 144.54 million in 2020.

Minapharm Pharmaceuticals is an Egypt-based company engaged in the production and distribution of pharmaceutical products. It is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.